The Pharmacokinetics of Ketorolac Tromethamine Administered Intranasally (IN) for Postoperative Pain in Children Aged 12 Through 17 Years

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

May 31, 2008

Conditions

Postoperative Pain

Interventions

DRUG

Ketorolac Tromethamine

Single IN dose of 15 mg ketorolac tromethamine for subjects weighing \<50 kg.

DRUG

Ketorolac Tromethamine

Single IN dose of 30 mg ketorolac tromethamine for subjects weighing ≥50 kg.

Trial Locations (1)

Stanford University Medical Center, Stanford